Pearl Huang, based in Cambridge, MA, US, is currently a CEO at Dunad Therapeutics, bringing experience from previous roles at Dunad Therapeutics, BB Biotech, Waters Corporation and Cygnal Therapeutics. Pearl Huang holds a Massachusetts Institute of Technology. With a robust skill set that includes Drug Discovery, Biotechnology, Molecular Biology, Oncology, Cancer and more, Pearl Huang contributes valuable insights to the industry. Pearl Huang has 7 emails and 1 mobile phone number on RocketReach.